Mir Subías, Alberto <br/><br/>
[Multiple sclerosis as an adverse effect of anti-tumor necrosis factor agents: an infrequent but important complication of infliximab in Crohn's disease].  [electronic resource] 

 -  Gastroenterologia y hepatologia  Feb 2013 
 - 81-5 p.  digital 
<br/><br/> Publication Type: Case Reports; English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>0210-5705 
<br/><br/><label>Standard No.: </label>10.1016/j.gastrohep.2012.07.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Antibodies, Monoclonal--adverse effects<br/>Crohn Disease--drug therapy<br/>Female<br/>Humans<br/>Infliximab<br/>Middle Aged<br/>Multiple Sclerosis--chemically induced<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors